S Zeuzem - Concepedia

Author

S Zeuzem

Goethe University Frankfurt

Also Known As

H. L. Y. Chan, S ZEUZEM, S Zeuzem, S. Zeuzem, Stefan Zeuzem, Zeuzem, Stefan

161

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Goethe University Frankfurt University Hospital Frankfurt Charité - Universitätsmedizin Berlin Ludwig-Maximilians-Universität München Saarland University

About

S Zeuzem is an author at Goethe University Frankfurt specializing in medicine, hepatitis, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	817
2	Hepatology	3	3	722
3	Immunology	3	3	310
4	Cell Biology	1	1	38
5	Cellular Physiology	1	1	38

S Zeuzem

Publications

876

Citations

H-Index

Page 1

	Year	Citations
Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 31, 2 S Zeuzem Journal of Hepatology HepatologyHepatitis CViral HepatitisHepatitis BHepatitis	2004	431
Prediction of Treatment Outcome in Patients With Chronic Hepatitis C: Significance of Baseline Parameters and Viral Dynamics During Therapy Thomas Berg, Christoph Sarrazin, Eva Herrmann, Hepatology Week 24Hcv-rna DeclineHepatologyHepatitis CViral Persistence	2003	274
EGF Stimulates Polyamine Uptake in Caco-2 Cells Vladan Milović, C. Deubner, S Zeuzem, Biochemical and Biophysical Research Communications Caco-2 CellsSignal TransductionMolecular PhysiologyCellular BiochemistryCell Growth	1995	38
Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients S Zeuzem, Ernst Scheuermann, Dorothee Waschk, Kidney International Hepatitis CViral DiagnosticsViral HepatitisHepatitisVirology	1996	38
Chronic Hepatitis B Monitoring and Treatment Patterns in Five European Countries with Different Access and Reimbursement Policies Victoria Aramă, Hakan Leblebicioğlu, Krzysztof Simon, Antiviral Therapy	2013	22
78 The HCV NS3 protease inhibitor SCH 503034 in combination with PEG-IFNα-2b in the treatment of HCV-1 PEG-IFNα-2b non-responders: Antiviral activity and HCV variant analysis S Zeuzem, C. Sarrazin, Frank Wagner, Journal of Hepatology Viral HepatitisAntiviral ActivityHcv-1 Peg-ifnα-2b Non-respondersImmunologyAntiviral Drug Development	2006	19
Tenofovir disoproxil fumarate (TDF) for the treatment of HBeAg-positive chronic Hepatitis B: Week 72 TDF data and week 24 Adefovir dipivoxil switch data (Study 103) J. Petersen, M.P. Manns, S Mauss, Zeitschrift für Gastroenterologie Nucleotide AnalogueImmunologyHepatitis BMolecular BiologyTdf Data	2008	17
Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C. Robert M. Hoffmann, Thomas Berg, G Teuber, PubMed	1999	15
Self-Expandable Metal Stent for Malignant Colonic Obstruction: Outcome in Proximal vs. Left Sided Tumor Localization Andrea O. Tal, M. Friedrich-Rust, Wolf O. Bechstein, Zeitschrift für Gastroenterologie	2013	12
Hepatocellular Cancer Surveillance in Patients with Advanced Chronic Liver Disease Wenyi Gu, Victor de Lédinghen, Christophe Aubé, NEJM Evidence	2024	10

Page 1